Almirall

About Almirall

Almirall is a global biopharmaceutical company dedicated to the research, development, and commercialization of innovative medicines. Founded in 1943, the company has established itself as a leader in dermatology, with a strong focus on developing treatments for skin diseases and conditions.

With a commitment to improving patients’ lives, Almirall invests significantly in research and development, aiming to bring new therapies to market that address unmet medical needs. The company’s portfolio includes a range of prescription medications, as well as over-the-counter products that cater to various health concerns.

Almirall operates in multiple countries, with a strong presence in Europe and expanding reach in other global markets. The company collaborates with healthcare professionals, researchers, and institutions to foster innovation and enhance patient care.

In addition to its focus on dermatology, Almirall is also exploring opportunities in other therapeutic areas, including respiratory and autoimmune diseases. The company’s vision is to be a trusted partner in healthcare, providing effective solutions that empower patients and improve their quality of life.

Almirall is committed to sustainability and corporate social responsibility, actively engaging in initiatives that promote health education and access to medicines. The company values diversity and inclusion, fostering a workplace culture that encourages collaboration and creativity.

As Almirall continues to grow, it remains dedicated to its mission of advancing healthcare through science and innovation, striving to make a positive impact on the communities it serves.